Cours Medovex Corp Nasdaq
Actions
US58504H1014
Equipement et technologie médicale avancés
CA 2021 | 1,61 M 1,47 M | CA 2022 | 453 k 414 k | Capitalisation | 1,62 M 1,48 M |
---|---|---|---|---|---|
Résultat net 2021 | -4 M -3,65 M | Résultat net 2022 | -10 M -9,14 M | VE / CA 2021 | 7,95 x |
Dette nette 2021 | 3,52 M 3,22 M | Dette nette 2022 | 3,92 M 3,58 M | VE / CA 2022 | 12,2 x |
PER 2021 |
-1,73
x | PER 2022 |
-0,08
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 35,62% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 53 | 08/01/19 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 04/02/19 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 15/06/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 65 | 17/01/22 | |
Chief Executive Officer | 53 | 08/01/19 | |
William E. Horne
BRD | Director/Board Member | 70 | 09/10/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+7,50% | 219 Md | |
+5,60% | 183 Md | |
+10,17% | 132 Md | |
+23,75% | 106 Md | |
-2,51% | 62,09 Md | |
+4,81% | 50,88 Md | |
+11,04% | 50,8 Md | |
-0,63% | 40,64 Md | |
+24,72% | 31,59 Md |